In isolation, the catabolic and thermogenic actions of glucagon would be beneficial to individuals who are obese or have type 2 diabetes but these actions are inherently paired with the undesirable stimulation of gluconeogenesis and glycogenolysis
Study methods: Adult patients who were taking GLP-1s and scheduled to receive anesthesia at 3 hospitals between June 30, 2023, and August 15, 2024, were evaluated via preoperative point-of-care gastric ultrasonography (GUS)
He did this despite the drug not having proven effectiveness or safety
Human evidence - Phase 3 TRIUMPH-1 (Eli Lilly, May 21, 2026) 2,339 adults with obesity or overweight without diabetes
Interestingly, thickening of the tissues in some places of epidermis may be indicative of deposition like callose